Posted in | News | Nanomedicine

Sydney to Host Third International Nanomedicine Conference

The future of medicine is migrating towards nano-scale thanks to the developments in nanotechnology, thus realizing healthcare solutions that once believed to be possible only in science fiction.

One nanometer is approximately 60,000-fold thinner when compared to the thickness of a human hair or equivalent to the size of a single DNA strand. From drugs with enhanced therapeutic properties that are capable of selectively targeting infected sites with cellular accuracy without causing damage to healthy tissue, to microscopic robots that are capable of circulating in the bloodstream to diagnose diseases and repair cells. All these advancements may become possible one day.

The Australian Centre for Nanomedicine at the University of New South Wales is the leader in this exhilarating new field and will conduct the third International Nanomedicine Conference from July 2 to 4, 2012, in Sydney.

Renowned clinicians and academics will take part in the conference to discuss significant research on regenerative medicine, diagnostics and imaging, and targeted drug delivery systems, all made possible by nanomedicine.

Researchers manipulate the exotic physical, chemical and biological properties of materials at the nano-scale for building systems and devices that are capable of developing more efficient therapies and enhance disease detection.

The Australian Centre for Nanomedicine at the University of New South Wales, which covers engineering, science and medicine, is exploring ways to improve diagnosis and treatment of diseases, including Parkinson's disease, Alzheimer's, multiple sclerosis, diabetes, and cancer.

Keynote speakers include Professor Alan Trounson, President of the California Institute for Regenerative Medicine; and Professor John Pickup Professor of Diabetes and Metabolism at King's College London.

Source: http://www.unsw.edu.au/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 12). Sydney to Host Third International Nanomedicine Conference. AZoNano. Retrieved on April 24, 2024 from https://www.azonano.com/news.aspx?newsID=25078.

  • MLA

    Thomas, G.P.. "Sydney to Host Third International Nanomedicine Conference". AZoNano. 24 April 2024. <https://www.azonano.com/news.aspx?newsID=25078>.

  • Chicago

    Thomas, G.P.. "Sydney to Host Third International Nanomedicine Conference". AZoNano. https://www.azonano.com/news.aspx?newsID=25078. (accessed April 24, 2024).

  • Harvard

    Thomas, G.P.. 2019. Sydney to Host Third International Nanomedicine Conference. AZoNano, viewed 24 April 2024, https://www.azonano.com/news.aspx?newsID=25078.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.